| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.24 | 0.2 |